hubergroup India expands its support for rural healthcare
hubergroup’s two newly added medical vans are dedicated to dental and eye care
hubergroup’s two newly added medical vans are dedicated to dental and eye care
Mindset disagrees with and denies the allegations set forth from Reunion.
These patches can be used in settings where patients need close vital signs monitoring, including cardiac rhythm.
he product will be launched shortly in the US market.
The portfolio includes approximately 45 commercial products, four pipeline products and 40 approved non-marketed products, including a number of generic products focused on women’s health.
The agreement between Eli Lilly and Janssen was established to allow the two companies to share resources for the goal of accelerating the evaluation of the respective companies’ assets, mirikizumab and Tremfya (guselkumab).
ANSSI Wellness launches Asia’s premier and USA-patented ‘Spinal Decompression Treatment’ center in Nashik
Diclofenac epolamine topical system 1.3% offers patients a non-opioid topical treatment
Allam was serving recently as the CEO at Public Investment Fund
Ryzneuta is a novel dimeric G- CSF long-acting fusion protein without pegylation. The Biologics License Application (BLA) of Ryzneuta is currently under late-stage review by the US FDA for Chemotherapy-Induced Neutropenia (CIN)
Subscribe To Our Newsletter & Stay Updated